NCT04438304 2025-02-12A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)Clarity Pharmaceuticals LtdPhase 2 Completed45 enrolled